Search by Journal
- HOME
- > Search by Journal
- > Journal of Clinical and Experimental Hematopathology
Journal of Clinical and Experimental Hematopathology
Volume 62, Issue 3 / 2022
English Article Japanese Article
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Castleman disease and mimickers: Clinicopathological findings of atypical lymphoproliferative disorders associated with autoimmune disease Yoshimasa Nakazato1), Shigeru Tsuchida2), Atsuko Takada-Owada1), Masato Onozaki1), Shuhei Noda1), Yumi Nozawa1), Mina Takaoka1), Kazuyuki Ishida1) Journal of Clinical and Experimental Hematopathology 62(3): 119-126, 2022. |
Lymphoma Microenvironment in DLBCL and PTCL-NOS : the key to uncovering heterogeneity and the potential for stratification Kohta Miyawaki, Takeshi Sugio Journal of Clinical and Experimental Hematopathology 62(3): 127-135, 2022. |
Efficacy and safety of ibrutinib in relapsed / refractory CLL and SLL in Japan : a post-marketing surveillance Ai Omi1), Fumi Nomura2), Shigeharu Tsujioka2), Akiko Fujino2), Reiko Akizuki1) Journal of Clinical and Experimental Hematopathology 62(3): 136-146, 2022. |
Addition of bortezomib to high-dose cyclophosphamide therapy as a conditioning regimen for autologous peripheral blood stem cell harvest leads to an increased yield of hematopoietic stem cells Sayaka Ohno1), Kiyohito Hayashi1), Ryo Shimizu1), Akihiro Ishii2), Hiroaki Tanaka1) Journal of Clinical and Experimental Hematopathology 62(3): 147-153, 2022. |
Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events Kantaro Ishitsuka1), Yasuhisa Yokoyama1,2), Naoko Baba1), Ryota Matsuoka3), Noriaki Sakamoto3), Tatsuhiro Sakamoto1,2), Manabu Kusakabe1,2), Takayasu Kato1,2), Naoki Kurita1,2), Hidekazu Nishikii1,2), Mamiko Sakata-Yanagimoto1,2), Naoshi Obara1,2), Yuichi Hasegawa1,2), Shigeru Chiba1,2) Journal of Clinical and Experimental Hematopathology 62(3): 154-157, 2022. |
Quantitative evaluation of treatment response to lenalidomide by applying fluorescence in situ hybridization for peripheral blood granulocytes in a patient with 5q-syndrome Hirotaka Sakai1,2), Ikuo Miura2,3), Ayako Arai2) Journal of Clinical and Experimental Hematopathology 62(3): 158-163, 2022. |
Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation Masahiro Miyazaki1), Satoshi Ichikawa1), Yasushi Onishi1), Noriko Fukuhara1), Eijiro Furukawa1), Koichi Onodera1), Hisayuki Yokoyama1), Ryo Ichinohasama2), Hideo Harigae1) Journal of Clinical and Experimental Hematopathology 62(3): 164-168, 2022. |
Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma Hideharu Domoto1), Takahiro Araki2), Asuka Ogai2), Michiko Inukai3), Chien K Chen2), Sakura Tomita4), Kiyoshi Mukai1), Naoya Nakamura4) Journal of Clinical and Experimental Hematopathology 62(3): 169-174, 2022. |
Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia Anna Kawashiri1), Shun-ichiro Nakagawa1), Chisato Ishiguro1), Kanako Mochizuki1), Yoshinobu Maeda2), Toshiro Kurokawa1) Journal of Clinical and Experimental Hematopathology 62(3): 175-180, 2022. |
Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation Masuho Saburi1), Masanori Sakata1), Kazuki Okuhiro2), Katsuya Kawano3), Souhei Uesugi4), Junpei Wada5), Shogo Urabe5), Yoshio Saburi1), Eiichi Ohtsuka1) Journal of Clinical and Experimental Hematopathology 62(3): 181-186, 2022. |
CD19 immunostaining of a stored paraffin-embedded vitrectomy cell block of intraocular lymphoma contributing to chimera antigen receptor T-cell therapy Toshihiko Matsuo1,2), Takehiro Tanaka3), Nobuharu Fujii4), Kentaro Fujii5), Eisei Kondo6) Journal of Clinical and Experimental Hematopathology 62(3): 187-189, 2022. |